Citation Impact
Citing Papers
Pegylated interferon alfa-2b alone or in combination with lamivudine for HBeAg-positive chronic hepatitis B: a randomised trial
2005 Standout
Changes in Utilization and Discard of Hepatitis C–Infected Donor Livers in the Recent Era
2016
Management of hepatitis B
2007
Mitochondrial dysfunction and biogenesis: do ICU patients die from mitochondrial failure?
2011
Treatment of recurrent hepatitis C after liver transplantation: a pilot study of peginterferon alfa-2b and ribavirin combination
2004
A Simple Noninvasive Index Can Predict Both Significant Fibrosis and Cirrhosis in Patients With Chronic Hepatitis C
2003 Standout
Diagnosis, management, and treatment of hepatitis C†
2004
Adverse effects of immune-checkpoint inhibitors: epidemiology, management and surveillance
2019 Standout
Hepatocellular carcinoma
2003 Standout
Reversion of disease manifestations after HCV eradication
2016
Regulation of microRNA function in animals
2018 Standout
Hepatitis B Virus Infection — Natural History and Clinical Consequences
2004 Standout
Peginterferon alfa‐2a for hepatitis C after liver transplantation
2005
Early Hepatic Stellate Cell Activation Predicts Severe Hepatitis C Recurrence after Liver Transplantation
2005
Primary liver cancer: Worldwide incidence and trends
2004 Standout
Survival and recurrence of hepatitis C after liver transplantation in patients coinfected with human immunodeficiency virus and hepatitis C virus
2007
Hepatitis C and liver transplantation
2005 Nature
A randomized study on Peg-interferon alfa-2a with or without ribavirin in liver transplant recipients with recurrent hepatitis C
2007
New Era of Liver Transplantation for Hepatitis B
2002
Hepatocellular carcinoma, human immunodeficiency virus and viral hepatitis in the HAART era
2008
A robust cell culture system supporting the complete life cycle of hepatitis B virus
2017 StandoutNobel
Antiviral therapy of chronic hepatitis C in patients with advanced liver disease and after liver transplantation
2009
Hepatitis B and Hepatitis C Viruses in Liver Transplantation
2004
A randomized, open-label study to evaluate the safety and pharmacokinetics of human hepatitis C immune globulin (Civacir) in liver transplant recipients
2005
Randomised trial of interferon α2b plus ribavirin for 48 weeks or for 24 weeks versus interferon α2b plus placebo for 48 weeks for treatment of chronic infection with hepatitis C virus
1998 Standout
Melioidosis as an emerging global problem
2000
Outcomes of patients with hepatitis C undergoing simultaneous liver–kidney transplantation
2009
Pegylated Interferon Alfa-2a and Ribavirin for Recurrent Hepatitis C After Liver Transplantation
2005
Impact of donor infections on outcome of orthotopic liver transplantation
2003
Hepatitis C
2015
Trial of Tocilizumab in Giant-Cell Arteritis
2017 Standout
Preoperative tumour biopsy does not affect the oncologic course of patients with transplantable HCC
2014
Report of the Monothematic EASL Conference on Liver Transplantation for Viral Hepatitis
2006
Lethal Mutagenesis of Hepatitis C Virus Induced by Favipiravir
2016 StandoutNobel
Melioidosis
2003 Standout
Drug-Induced Hepatotoxicity
2003 Standout
The efficacy and safety comparison between tenofovir and entecavir in treatment of chronic hepatitis B and HBV related cirrhosis: A systematic review and Meta-analysis
2016
Hepatocellular carcinoma
2012 Standout
Melioidosis
2012 Standout
Hepatic venous pressure gradient identifies patients at risk of severe hepatitis C recurrence after liver transplantation
2006
Hepatitis B virus infection
2009 Standout
Use of hepatitis B core antibody-positive donors for liver transplantation
2002
Glucocorticosteroids Increase Cell Entry by Hepatitis C Virus
2010
Lamivudine for Patients with Chronic Hepatitis B and Advanced Liver Disease
2004 Standout
Hepatitis C virus and microRNAs: miRed in a host of possibilities
2014
Efficacy, predictors of response, and potential risks associated with antiviral therapy in liver transplant recipients with recurrent hepatitis C
2006
Pegylated interferon plus ribavirin for recurrent Hepatitis C infection after liver transplantation in naïve and non-responder patients on a stable immunosuppressive regimen
2005
Diagnosis, management, and treatment of hepatitis C: An update # † ‡
2008 Standout
Monoclonal antibody HCV-AbXTL68 in patients undergoing liver transplantation for HCV: Results of a phase 2 randomized study
2006
Sofosbuvir/velpatasvir for 12 weeks in genotype 1–4 HCV-infected liver transplant recipients
2018
Management of Hepatocellular Carcinoma *
2005 Standout
Prevention and treatment of hepatitis C virus recurrence after liver transplantation
2004
A Human Monoclonal Antibody Targeting Scavenger Receptor Class B Type I Precludes Hepatitis C Virus Infection and Viral Spread In Vitro and In Vivo
2011 StandoutNobel
Entecavir and hepatitis B immune globulin in patients undergoing liver transplantation for chronic hepatitis B
2013
Hepatitis C and Liver Transplantation: Enhancing Outcomes and Should Patients Be Retransplanted
2008
Combined treatment with pegylated interferon (α-2b) and ribavirin in the acute phase of hepatitis C virus recurrence after liver transplantation
2005
Pros and Cons: Usage of organs from donors infected with hepatitis C virus – Revision in the direct-acting antiviral era
2015
Treating hepatitis C
2005 StandoutNobel
The phenoptosis problem: What is causing the death of an organism? Lessons from acute kidney injury
2012
Risk of Hepatocellular Carcinoma Across a Biological Gradient of Serum Hepatitis B Virus DNA Level
2006 Standout
Outcome after liver re-transplantation in patients with recurrent chronic hepatitis C
2007
Chronic hepatitis B
2007 Standout
Liver transplantation and hepatitis C
2011
Treatment of hepatitis C in difficult-to-treat patients
2015
Chronic hepatitis B: Update 2009 #
2009 Standout
American Gastroenterological Association Technical Review on the Management of Hepatitis C
2006
De novo hepatitis B after liver transplantation from hepatitis B core antibody—Positive donors in an area with high prevalence of anti-HBc positivity in the donor population
2001
Optimal management of hepatitis B virus infection – EASL Special Conference
2015
Treatment of hepatitis C
2005
Interferon alpha 2b and ribavirin for the treatment of recurrent hepatitis C after liver transplantation: Cohort study of 38 patients
2005
Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance
2009 StandoutNature
Systematic review: anti-viral therapy of recurrent hepatitis C after liver transplantation
2010
Hepatitis C Virus Infection and Bone Marrow Transplantation: A Cohort Study With 10–Year Follow–Up
1999
Antiviral therapy of patients with decompensated cirrhosis to prevent recurrence of hepatitis C after liver transplantation
2003
Occult hepatitis B virus infection
2006
Progression of Alphafetoprotein Before Liver Transplantation for Hepatocellular Carcinoma in Cirrhotic Patients: A Critical Factor
2009
Persistent Hepatitis B Virus Infection in Subjects Without Hepatitis B Surface Antigen: Clinically Significant or Purely “Occult”?
2001
Surgical approach for hepatitis C virus-related hepatocellular carcinoma
2015
Hepatitis C virus entry into hepatocytes: Molecular mechanisms and targets for antiviral therapies
2010
Recurrent hepatitis C genotype 1b following liver transplantation
2004
Treatment of Patients with Recurrent Hepatitis C after Liver Transplantation with Peginterferon Alfa-2B Plus Ribavirin
2006
Sustained virological response to antiviral therapy reduces mortality in HCV reinfection after liver transplantation
2006
Infection in Solid-Organ Transplant Recipients
2007 Standout
Recurrent Disease Following Liver Transplantation for Nonalcoholic Steatohepatitis Cirrhosis
2009
Second hepatitis C replication compartment indicated by viral dynamics during liver transplantation
2005
Preemptive Therapy for Hepatitis C Virus after Living-Donor Liver Transplantation
2004
Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial
2001 Standout
Interferon Alfa-2b Alone or in Combination with Ribavirin as Initial Treatment for Chronic Hepatitis C
1998 Standout
Monoclonal Anti-Claudin 1 Antibodies Prevent Hepatitis C Virus Infection of Primary Human Hepatocytes
2010
Antiretroviral Treatment of Adult HIV Infection
2012 Standout
The option of HBIG-free prophylaxis against recurrent HBV
2012
Sofosbuvir and Daclatasvir Combination Therapy in a Liver Transplant Recipient With Severe Recurrent Cholestatic Hepatitis C
2013
Hepatocellular Carcinoma
2011 Standout
Efficacy of Antiviral Therapy on Hepatitis C Recurrence After Liver Transplantation: A Randomized Controlled Study
2007
Controversies regarding and perspectives on clinical utility of biomarkers in hepatocellular carcinoma
2015
The way forward in HCV treatment — finding the right path
2007 StandoutNobel
Molecular characterization of intrahepatic and extrahepatic hepatitis B virus (HBV) reservoirs in patients on suppressive antiviral therapy
2010
Hepatic Stellate Cells: Protean, Multifunctional, and Enigmatic Cells of the Liver
2008 Standout
Infection in Organ-Transplant Recipients
1998 Standout
Prevalence, Patterns, and Course of Past Hepatitis B Virus Infection in Intravenous Drug Users With Hiv-1 Infection
2000
Hepatitis C Recurrence After Liver Transplantation: Viral and Histologic Response to Full-Dose Peg-Interferon and Ribavirin
2006
Hepatocellular carcinoma
2022 Standout
Antiviral treatment for chronic hepatitis B in renal transplant patients
2014
Replication of hepatitis C virus
2007 StandoutNobel
Hepatitis C Virus RNA Functionally Sequesters miR-122
2015 StandoutNobel
Flying Under the Radar: The Immunobiology of Hepatitis C
2006 StandoutNobel
EASL 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection
2017 Standout
Melioidosis: Epidemiology, Pathophysiology, and Management
2005 Standout
Effects of interferon treatment on liver histology and allograft rejection in patients with recurrent hepatitis C following liver transplantation
2004
Hepatitis C infection in the transplant recipient.
1995
Mitochondrial Reactive Oxygen Species (ROS) and ROS-Induced ROS Release
2014 Standout
Interferon-Free Regimens in the Liver-Transplant Setting
2014
Assessment of Liver Function in Patients With Hepatocellular Carcinoma: A New Evidence-Based Approach—The ALBI Grade
2014 Standout
Response of Hepatitis C Virus to Long-Term Passage in the Presence of Alpha Interferon: Multiple Mutations and a Common Phenotype
2013 StandoutNobel
Mathematical Modeling of Subgenomic Hepatitis C Virus Replication in Huh-7 Cells
2006 StandoutNobel
EASL Recommendations on Treatment of Hepatitis C 2018
2018 Standout
Tenofovir/entecavir monotherapy after hepatitis B immunoglobulin withdrawal is safe and effective in the prevention of hepatitis B in liver transplant recipients
2015
Human Fatty Liver Disease: Old Questions and New Insights
2011 StandoutScience
EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma
2018 Standout
Optimal timing of hepatitis C treatment for patients on the liver transplant waiting list
2016
Successful anti-scavenger receptor class B type I (SR-BI) monoclonal antibody therapy in humanized mice after challenge with HCV variants with in vitro resistance to SR-BI-targeting agents
2014 StandoutNobel
RNA editing of hepatitis B virus transcripts by activation-induced cytidine deaminase
2013 StandoutNobel
LIVER TRANSPLANTATION FOR CHRONIC VIRAL HEPATITIS
1999
Turmeric curcumin inhibits entry of all hepatitis C virus genotypes into human liver cells
2013 StandoutNobel
HEPATITIS C INFECTION IN THE TRANSPLANT RECIPIENT
1995
Different Requirements for Scavenger Receptor Class B Type I in Hepatitis C Virus Cell-Free versus Cell-to-Cell Transmission
2013 StandoutNobel
Management of patients with hepatitis B in special populations
2015
Works of Bruno Roche being referenced
Effectiveness and Safety of Tenofovir Disoproxil Fumarate in Chronic Hepatitis B: A 3-Year, Prospective, Real-World Study in France
2016
Hepatitis C virus viral recurrence and liver mitochondrial damage after liver transplantation in HIV–HCV co-infected patients
2004
Hepatitis C Virus Therapy in Liver Transplant Recipients: Response Predictors, Effect on Fibrosis Progression, and Importance of the Initial Stage of Fibrosis
2008
Risk factors for new-onset diabetes mellitus following liver transplantation and impact of hepatitis c infection : An observational multicenter study
2006
De novo and apparent de novo hepatitis B virus infection after liver transplantation
1997
Liver transplantation in viral hepatitis: Prevention of recurrence
2008
Treatment of Patients with HBV-related Decompensated Cirrhosis and Liver Transplanted Patients
2013
Hepatocellular Carcinoma Is Associated With an Increased Risk of Hepatitis B Virus Recurrence After Liver Transplantation
2008
The difficulties of managing severe hepatitis B virus reactivation
2011
Long-term follow-up of liver transplanted HIV/hepatitis B virus coinfected patients: perfect control of hepatitis B virus replication and absence of mitochondrial toxicity
2009
Treatment of hepatitis�B and C after liver transplantation. Part 1, hepatitis�B
2005
Retransplantation of the liver for recurrent hepatitis B virus infection: The Paul Brousse experience
1999
Treatment of hepatitis B and C after liver transplantation. Part 2, hepatitis C
2004
Diagnostic accuracy of FibroScan and comparison to liver fibrosis biomarkers in chronic viral hepatitis: A multicenter prospective study (the FIBROSTIC study)
2010
Interferon-α 2b plus ribavirin in patients with chronic hepatitis C after liver transplantation: A randomized study
2003
HEPATITIS C VIRUS INFECTION AND ALLOGENEIC BONE MARROW TRANSPLANTATION
1994
Liver transplantation for hepatitis B virus-related liver disease: Indications, prevention of recurrence and results
2003
Risk factors for hepatitis C recurrence after liver transplantation
2007
Safety and efficacy of protease inhibitors to treat hepatitis C after liver transplantation: A multicenter experience
2013
Characterization of liver injury induced by cancer immunotherapy using immune checkpoint inhibitors
2018
Residual hepatitis B virus particles in liver transplant recipients receiving lamivudine: PCR quantitation of HBV DNA and ELISA of preS1 antigen
2001
Optimal therapy in hepatitis C virus liver transplant patients with direct acting antivirals
2014
Current management and perspectives for HCV recurrence after liver transplantation
2013
Management of the hepatitis B virus in the liver transplantation setting: A European and an American perspective
2005
[Adult to adult living-related liver transplantation. The Paul-Brousse Hospital preliminary experience].
2001
Liver Transplantation in Delta Virus Infection
2012
Hepatitis C virus treatment pre‐ and post‐liver transplantation
2011
531 TENOFOVIR DF TREATMENT IS SAFE AND WELL TOLERATED IN CHRONIC HEPATITIS B (CHB) PATIENTS WITH BASELINE DECREASED GLOMERULAR FILTRATION RATE
2012
47 EFFICACY AND SAFETY OF PROTEASE INHIBITORS FOR SEVERE HEPATITIS C RECURRENCE AFTER LIVER TRANSPLANTATION: A FIRST MULTICENTRIC EXPERIENCE
2012
[Septic pyemic form of human melioidosis: a first case in the French Antilles].
1995
Incidence of Severe Infections and Infection‐Related Mortality During the Course of Giant Cell Arteritis: A Multicenter, Prospective, Double‐Cohort Study
2016